Suppr超能文献

[关于德国新型口服抗凝剂(NOAC)长期治疗患者急性冠状动脉综合征院前治疗共识声明的评论]

[Comments on the German consensus statement on prehospital treatment of acute coronary syndrome in patients under long-term treatment with novel oral anticoagulants (NOAC)].

作者信息

Schneck Emmanuel, Hamm Christian W, Schneck Franziska, Wolter Jan Sebastian, Dirkmann Daniel, Koch Christian, Sander Michael

机构信息

Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Gießen und Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, Rudolf-Buchheim-Straße 7, 35392, Gießen, Deutschland.

Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI e. V.), Berlin, Deutschland.

出版信息

Anaesthesist. 2021 Sep;70(9):785-788. doi: 10.1007/s00101-021-00943-6. Epub 2021 Mar 24.

Abstract

Despite an increasing number of patients suffering from an acute coronary syndrome under novel oral anticoagulant therapy, specific treatment recommendations for anticoagulation are still lacking. For this reason, the German Society of Cardiology and the German Association of Interdisciplinary Intensive Care and Emergency Medicine developed a consensus statement for the treatment of these patients with the aim to summarize the current evidence and to increase the safety of this special patient group.

摘要

尽管接受新型口服抗凝治疗的急性冠状动脉综合征患者数量不断增加,但针对抗凝治疗仍缺乏具体的治疗建议。因此,德国心脏病学会和德国跨学科重症监护与急诊医学协会制定了一份针对这些患者治疗的共识声明,旨在总结当前证据并提高这一特殊患者群体的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验